Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tomball, TX
NPI
1235209537
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
455 School St, Suite 22
Tomball, TX, 77375
Phone (281) 357-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
28,134 services
Medicare patients, 2024
545
Average age 74
Drug cost, 2024
$2.2M
6,681 prescriptions
Company payments, 2025
$6,425
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tariq Zia was code J0897 (injection, denosumab, 1 mg), 2,460 times for 24 patients. In total Tariq Zia billed 28,134 services in 27 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,460 | 24 | $20.55 | $51K |
| 99214 Office E&M - Established | Office | 1,101 | 377 | $87.64 | $96K |
| 99213 Office E&M - Established | Office | 418 | 230 | $56.33 | $24K |
| 95251 Test - Miscellaneous | Office | 172 | 97 | $24.96 | $4,293 |
| 83036 Blood Count | Office | 140 | 82 | $9.52 | $1,333 |
| 96372 Injection Administration | Office | 135 | 34 | $9.51 | $1,284 |
| 76536 Ultrasound - Nonspecific | Office | 113 | 111 | $74.37 | $8,404 |
| 99203 Office E&M - New | Office | 44 | 44 | $76.83 | $3,380 |
| 95250 Test - Miscellaneous | Office | 33 | 29 | $99.74 | $3,291 |
| 82947 Clinical Chemistry | Office | 22 | 22 | $3.85 | $84.7 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $86.23 | $948 |
By year: 2022 $265K for 21,529 services; 2023 $271K for 27,781 services; 2024 $236K for 28,134 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 140 | 82 | $9.52 | $1,333 |
| 82947 Clinical Chemistry | 22 | 22 | $3.85 | $84.7 |
Medicare prescription drug claims, 2024
In 2024, the drug Tariq Zia prescribed most often to Medicare patients was Levothyroxine Sodium, with 795 prescriptions and refills. In total Tariq Zia wrote 6,681 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 795 | 2,223 | 245 | $9,223 |
| Ozempic Semaglutide | 432 | 615 | 87 | $551K |
| Metformin Hcl Generic | 377 | 988 | 112 | $3,641 |
| Glimepiride Generic | 296 | 824 | 94 | $3,303 |
| Synthroid Levothyroxine Sodium | 206 | 501 | 56 | $17K |
| Jardiance Empagliflozin | 202 | 435 | 55 | $250K |
| Atorvastatin Calcium Generic | 176 | 500 | 66 | $1,806 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 140 | 335 | 51 | $27K |
| Rosuvastatin Calcium Generic | 137 | 377 | 44 | $1,596 |
| Methimazole Generic | 137 | 296 | 30 | $1,255 |
| Tresiba Flextouch U-100 Insulin Degludec | 119 | 306 | 37 | $145K |
| Pioglitazone Hcl Generic | 113 | 326 | 36 | $1,862 |
| Mounjaro Tirzepatide | 110 | 159 | 30 | $171K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 105 | 293 | 47 | $11K |
| Amlodipine Besylate Generic | 98 | 288 | 34 | $827 |
Brand drugs: 2,791 claims; generic drugs: 3,536 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tariq Zia $6,425 ($6,425 in general payments such as food, travel and fees) from 15 companies. The largest payer was Senseonics, Incorporated with $5,040.
| Company | Payments | Amount |
|---|---|---|
| Senseonics, Incorporated SENS | 13 | $5,040 |
| Novo Nordisk Inc NVO | 10 | $219 |
| Ascensia Diabetes Care Us Inc. | 13 | $205 |
| Amgen Inc. AMGN | 5 | $160 |
| Amneal Pharmaceuticals LLC AMRX | 9 | $139 |
| Insulet Corporation PODD | 6 | $127 |
| Medtronic, Inc. MDT | 3 | $86.87 |
| Tandem Diabetes Care, Inc. TNDM | 5 | $81.29 |
| Abbvie Inc. ABBV | 4 | $79.9 |
| Madrigal Pharmaceuticals MDGL | 2 | $76.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.